Search results

15 items matching your search terms.
Filter the results.
Item type












New items since



Sort by relevance · date (newest first) · alphabetically
NEW RESEARCH | Risk Factors for Fecal Incontinence in Older Women
Recent research about the risk factors associated with fecal incontinence.
Located in News
July 1, 2014 | Pelvic Health Clinic Relocating to UNC Hillsborough Campus
Effective July 1, 2014, the UNC Pelvic Health outpatient practice, currently located on the UNC Campus in Chapel Hill, will move to the UNC Hillsborough Campus.
Located in News
GYN | VAULT study for pelvic organ prolapse
STUDY BRIEF | The purpose of this research study is to learn about the effectiveness of 2 surgical techniques for treatment of uterovaginal prolapse: Laparoscopic/ robotic-assisted sacral hysteropexy and Vaginal Uphold Hysteropexy will be compared. Both procedures leave the uterus in place and use mesh to support the uterus and vagina. The cure rates, complications, and improvement of symptoms after these two procedures will be compared.
Located in Research / Ongoing
NEW CLINICS | UNC Women's Care opening two clinics in Hillsborough
Effective July 1, 2013 UNC Women's Care will open new clinics at the UNC Hillsborough campus.
Located in News
VIDEO | One in five women undergoes urogynecologic surgery
At the recent annual meeting for the American Urogynecologic Society, UNC's Dr. Wu talked about some startling research statistics.
Located in News
Should a Woman’s Ovaries Be Removed During a Hysterectomy for Noncancerous Disease?
Dr. Matthews emphasizes the difficult choice women must often make.
Located in News
PROMOTION | Geller
Dr. Elizabeth Geller receives an academic promotion.
Located in News
Spend an evening at the spa and get back to enjoying your life!
Skin Sense, a day spa and UNC Pelvic Health invite you to meet their providers.
Located in News
GYN | ACE Trial for Overactive Bladder
Study Brief | The purpose of the ACE trial is to assess cognitive function in women taking an anticholinergic medication (trospium) for the treatment of overactive bladder. This medication is FDA-approved and is not experimental. There are rare reports of changes in cognitive function when taking any anticholinergic medication for overactive bladder. The goal is to administer written cognitive function tests to measure your cognitive function before and after starting medication.
Located in Research / Ongoing
GYN | The URGE Trial
Study Brief | The purpose of this research study is to determine genes that affect how a person’s body metabolizes a drug can help us predict how women will respond to a FDA approved medication (fesoterodine fumarate) for urgency urinary incontinence (UUI).
Located in Research / Ongoing